Washington roundup: Public supports growing clamor for Senate vote on ESC funding May 19, 2006 By Aaron Lorenzo
Neurocrine Shares Dumped As FDA Sets Back Indiplon May 17, 2006 By Aaron Lorenzo The FDA delayed approving an immediate-release version of the sleep drug indiplon and rejected a modified-release formulation, actions that on Tuesday crushed the stock of Neurocrine Biosciences Inc. (BioWorld Today)Read More
